Clinical Trial Update: Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating two dosing regimens of Ferrlecit (iron sucrose) for iron deficiency anemia in pediatric patients on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• FERRLECIT (SODIUM FERRIC GLUCONATE COMPLEX)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Anemia | Phase 4 | Status: COMPLETED